JRCT ID: jRCT2080225232
Registered date:17/06/2020
Basic Information
| Recruitment status | completed |
|---|---|
| Health condition(s) or Problem(s) studied | |
| Date of first enrollment | 29/06/2020 |
| Target sample size | 30 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : |
Outcome(s)
| Primary Outcome | safety other |
|---|---|
| Secondary Outcome | safety other |
Key inclusion & exclusion criteria
| Age minimum | >= 20age old |
|---|---|
| Age maximum | <= 65age old |
| Gender | Both |
| Include criteria | |
| Exclude criteria |
Related Information
| Primary Sponsor | |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) | NCT04463472,JapicCTI-205328 |
Contact
| Public contact | |
| Name | |
| Address | |
| Telephone | |
| info@anges.co.jp | |
| Affiliation | |
| Scientific contact | |
| Name | |
| Address | |
| Telephone | |
| anges-cr@anges.co.jp | |
| Affiliation | |